Neurodegenerative Diseases Related Content

Learn about these five rare diseases to support governments, scientists and healthcare professionals to find treatments.

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.

Medical researchers in Britain and Japan are to join forces in the fight to advance research into treatments for degenerative diseases.

Andrea Varrone studies the importance of molecular imaging to provide personalised medicine and improve care for patients with neurodegenerative disorders

Prof Dr Regina Fluhrer from Biomedical Center (BMC), Ludwig Maximilians University of Munich (LMU) & German Center for Neurodegenerative Diseases (DZNE) shares her expertise on the field of intramembrane proteases, focussing on regulation of cellular pathways

The work of the EU Joint Programme – Neurodegenerative Disease Research (JPND) which aims to tackle the challenge of these diseases, in particular, Alzheimer’s, is discussed here

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?

Dr. Sanchez discusses his research into the auditory system in order to develop therapeutic approaches for people with hearing impairment Neurons within the auditory pathway utilise specialised biophysical properties to precisely encode elements of sound important for normal hearing. For individuals with hearing impairments – like age-related hearing loss, auditory neuropathy, and central auditory...

Dr Yves Joanette, Scientific Director at the CIHR Institute of Aging argues for a balanced approach when it comes to their collaboration-based approach to face the challenge of dementia

Jennifer J. McComas from the University of Minnesota discusses the current evidence for communication intervention for individuals with Rett syndrome

The vital work of the National Institute on Deafness and Other Communication Disorders (NIDCD) and The National Institute of Neurological Disorders and Stroke (NINDS) are explored here by Open Access Government, with a special focus on neurodegenerative disorders.

Tamas Fulop from Université de Sherbrooke’s Research Center on Aging, explains precisely why infections may be the new paradigm explaining the pathogenesis of Alzheimer’s disease (AD)

The DZNE investigates the causes of neurodegenerative diseases and develops novel strategies for prevention, treatment and care.

NIH-funded study closes in on personalised drug testing for neurological disorders

Scientists from the National Institutes of Health (NIH) compared the genetic clocks of normal and mutant flies to understand the link between neurodegenerative disorders such as Alzheimer’s disease and the ageing process

Svein Olaf Olsen and Maiken Arnesen from the European Huntington Association reveal their thoughts on a recent and significant breakthrough concerning Huntington’s Disease (HD) research The 11th December 2017 will probably go into history along with the discovery of the Huntington gene in 1993. On this date, IONIS Pharmaceuticals announced...

UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...

The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...

The defect that causes Huntington's disease has been corrected in patients for the first time with an experimental drug Experts believe that the new experimental drug, which is injected into spinal fluid, could be the biggest breakthrough in neurodegenerative diseases for 50 years. The unstoppable death of brain cells in Huntington's gradually causes...

Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging